CD44 and hepatocellular carcinoma: As with the observation for FOXM1, the total cohort of patients with HCC and higher expression of CD44, SOX2, ABCG2, and VIMENTIN exhibited a poorer prognosis than patients with HCC and lower expressions of these proteins (Figure 8B,C).